Blog

Explore how NAMs are advancing DILI prediction in preclinical toxicology and why hepatic cell quality is key to improving liver sa...

Discover how the FDA Modernization Act 2.0 and human iPSCs are moving drug discovery beyond animal models to improve predictive va...

Read the blog to find out how perturbations shape cell identity at industrial scale.

Discover how the FDA Modernization Act 2.0 and human iPSCs are moving drug discovery beyond animal models to improve predictive va...

In this article, we recapitulate the highlights of SfN 2025.

Explore how iPSC-derived models are transforming cell-based drug discovery with scalable, human-relevant assays that improve trans...

In this article, we explore how easy access to gene expression data can help advance treatments for ultra-rare diseases.

HMC3 cells lack key microglial features. Learn why labs are switching to ioMicroglia—human iPSC-derived, functional, and consisten...